{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:08:53Z","timestamp":1788138533494,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SS2019060"],"award-info":[{"award-number":["SS2019060"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671270"],"award-info":[{"award-number":["81671270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["XKQ2015002"],"award-info":[{"award-number":["XKQ2015002"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jad.2022.08.097","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T22:29:48Z","timestamp":1662157788000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Botulinum toxin A (BoNT\/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China"],"prefix":"10.1016","volume":"318","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.08.097_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/apc.2012.0406","article-title":"Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care","volume":"27","author":"Bess","year":"2013","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.jad.2022.08.097_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2009.06.040","article-title":"Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants","volume":"61","author":"Brin","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2022.08.097_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/YIC.0000000000000290","article-title":"OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females","volume":"35","author":"Brin","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.08.097_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuroscience.2017.03.049","article-title":"Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection","volume":"352","author":"Cai","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2022.08.097_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2017.10.027","article-title":"Direct central nervous system effects of botulinum neurotoxin","volume":"147","author":"Caleo","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.jad.2022.08.097_bb0035","first-page":"228","article-title":"Rapid and sustained antidepressant action of the mGlu2\/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine","volume":"20","author":"Dong","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2022.08.097_bb5000","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.608857","article-title":"Magnetic resonance spectroscopy in depressed subjects treated with electroconvulsive therapy\u2014a systematic review of literature","volume":"12","author":"Erchinger","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.097_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","article-title":"Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial","volume":"52","author":"Finzi","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.08.097_bb0045","first-page":"645","article-title":"Treatment of depression with botulinum toxin a: a case series","volume":"32","author":"Finzi","year":"2006","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.jad.2022.08.097_bb0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12916-020-01738-z","article-title":"Comorbidity between depression and anxiety: assessing the role of bridge mental states in dynamic psychological networks","volume":"18","author":"Groen","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2022.08.097_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1067\/S0190-9622(03)00909-5","article-title":"Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear","volume":"49","author":"Heckmann","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2022.08.097_bb0060","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1162\/jocn_a_00622","article-title":"The face of negative affect: trial-by-trial corrugator responses to negative pictures are positively associated with amygdala and negatively associated with ventromedial prefrontal cortex activity","volume":"26","author":"Heller","year":"2014","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.jad.2022.08.097_bb0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cercor\/bhn104","article-title":"The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles","volume":"19","author":"Hennenlotter","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jad.2022.08.097_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4605971","article-title":"New treatment strategies of depression: based on mechanisms related to neuroplasticity","volume":"2017","author":"Huang","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.jad.2022.08.097_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fpsyt.2019.00315","article-title":"The reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D) for Chinese university students","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.097_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2045-5380-4-11","article-title":"Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design","volume":"4","author":"Kim","year":"2014","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.jad.2022.08.097_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2014.00098","article-title":"Spinal central effects of peripherally applied botulinum neurotoxin a in comparison between its subtypes A1 and A2","volume":"5","author":"Koizumi","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jad.2022.08.097_bb0090","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.neuroimage.2012.05.044","article-title":"Amygdala-prefrontal coupling underlies individual differences in emotion regulation","volume":"62","author":"Lee","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.jad.2022.08.097_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.552416","article-title":"Play mode effect of exergames on subthreshold depression older adults: a randomized pilot trial","volume":"11","author":"Li","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2022.08.097_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12264-019-00367-8","article-title":"Antidepressant-like action of single facial injection of botulinum neurotoxin a is associated with augmented 5-HT levels and BDNF\/ERK\/CREB pathways in mouse brain","volume":"35","author":"Li","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jad.2022.08.097_bb0105","article-title":"Botulinum neurotoxin therapy for depression: therapeutic mechanisms and future perspective","volume":"12","author":"Li","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.097_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02040-8","article-title":"Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a\/SYK\/NF-\u03baB axis","volume":"18","author":"Li","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2022.08.097_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.13m08845","article-title":"Treatment of major depressive disorder using botulinum toxin a: a 24-week randomized, double-blind, placebo-controlled study","volume":"75","author":"Magid","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.097_bb0120","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1113\/jphysiol.2012.239178","article-title":"Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin a","volume":"591","author":"Marchand-Pauvert","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.jad.2022.08.097_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bph.14846","article-title":"Evidence for central antispastic effect of botulinum toxin type a","volume":"177","author":"Matak","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jad.2022.08.097_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1073858414524633","article-title":"More than at the neuromuscular synapse: actions of botulinum neurotoxin a in the central nervous system","volume":"21","author":"Mazzocchio","year":"2015","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jad.2022.08.097_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.08.097_bb0140","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1038\/srep05894","article-title":"Quick concurrent responses to global and local cognitive information underlie intuitive understanding in board-game experts","volume":"4","author":"Nakatani","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2022.08.097_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12888-017-1404-1","article-title":"Minor depression in older, long-term unemployed people seeking vocational support","volume":"17","author":"Pfeil","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2022.08.097_bb0150","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin a (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2022.08.097_bb0155","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jad.2022.08.097_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11606-019-05192-3","article-title":"The role of screening in depression diagnosis and treatment in a representative sample of US primary care visits","volume":"35","author":"Samples","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jad.2022.08.097_bb0165","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpsychires.2012.01.027","article-title":"Facing depression with botulinum toxin: a randomized controlled trial","volume":"46","author":"Wollmer","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.08.097_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2333","article-title":"The safety and efficacy of botulinum toxin a on the treatment of depression","volume":"11","author":"Zhang","year":"2021","journal-title":"Brain Behav."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722009557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722009557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:22:29Z","timestamp":1759029749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722009557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"alternative-id":["S0165032722009557"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.097","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin A (BoNT\/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}